Impact of " No-touch " Technique on the Outcome of Liver Transplantation for Hepatocellular Carcinoma
Conditions: Liver Transplantation; No-touch Technique; Hepatocellular Carcinoma Interventions: Procedure: Liver transplantation with " No-touch " technique Sponsors: Zhejiang University; Shulan (Hangzhou) Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma
Conditions: Liver Transplantation; Hepatocellular Carcinoma; Alpha-Fetoprotein; Protein Induced by Vitamin K Absence or Antagonist-II Sponsors: Zhejiang University; Shulan (Hangzhou) Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Evaluation of Cirrhotic Cardiomyopathy by Cardiac MRI in Patients Waiting for Liver Transplant.
Conditions: Cirrhosis Interventions: Diagnostic Test: MRI; Biological: Blood sampling Sponsors: Centre Hospitalier Universitaire de Besancon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
Conditions: Hematopoietic Stem Cell Transplant Interventions: Behavioral: PATH Sponsors: Brigham and Women ' s Hospital; Dana-Farber Cancer Institute; Duke University; H. Lee Moffitt Cancer Center and Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Transplanting Lungs From Uncontrolled Donation After Circulatory Death
Conditions: Lung Transplantation Interventions: Device: Lung uDCD Protocol Sponsors: NYU Langone Health; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Chaplain-Delivered Compassion Meditation to Improve Spiritual Care of Patients Receiving Stem Cell Transplantation
Conditions: Lymphoma; Multiple Myeloma Interventions: Procedure: Spiritual Therapy; Other: Best Practice Sponsors: Emory University; National Cancer Institute (NCI); National Center for Complementary and Integrative Health (NCCIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
CAPABLE Transplant
Conditions: Quality of Life; Depression; End Stage Renal Disease; Disability Physical Interventions: Behavioral: CAPABLE Transplant- Open Label Pilot; Behavioral: CAPABLE Transplant- Randomized Control Trial Sponsors: Johns Hopkins University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Research on Precision Pharmaceutical Care for Heart Transplant Recipients
Conditions: Heart Transplant Patients Sponsors: Nanjing First Hospital, Nanjing Medical University; Wuhan Union Hospital, China; Changhai Hospital; Shanghai Zhongshan Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Exercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart Disease
Conditions: Pediatric ALL; Congenital Heart Disease; Heart Transplantation Interventions: Diagnostic Test: Exercise cardiac MRI Assessment; Diagnostic Test: Cardiopulmonary Exercise Test Sponsors: University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
The effects of Phoniatric PREhabilitation in Head and Neck Cancer patients on Aspiration and Preservation of Swallowing (PREHAPS): study protocol of a monocentric prospective randomized interventional outcome-blinded trial
DiscussionPrehabilitation measures have already proven successful in other patient groups, e.g., transplant patients. In the field of head and neck oncology, interest in such concepts has increased significantly in recent years. However, usually, only subgroups, e.g., patients with swallowing problems after radiochemotherapy alone, are in focus. Our study aims to investigate the general benefit of prehabilitation with regard to swallowing function, which is so important for protection of aspiration and quality of life.Trial registrationGerman Clinical Trials RegisterDRKS00029676. International Clinical Trials Registry Pl...
Source: Trials - March 22, 2024 Category: Research Source Type: clinical trials
Tocilizumab in chronic active antibody-mediated rejection: rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT study)
DiscussionNo effective treatment exists for caAMR at present. Based on the hypothesis that inhibition of IL-6 receptor by tocilizumab will reduce antibody production and reduce antibody-mediated damage, our randomized trial has a potential to provide evidence for a novel treatment strategy for caAMR, therewith slowing the decline in graft function in the long-term.Trial registrationClinicalTrials.gov NCT04561986. Registered on September 24, 2020 (Source: Trials)
Source: Trials - March 22, 2024 Category: Research Source Type: clinical trials
HI-Bio Receives FDA Orphan Drug Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection (AMR) in Kidney Transplant Recipients
SOUTH SAN FRANCISCO, Calif.,– March 21, 2024– Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), today announced... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 21, 2024 Category: Pharmaceuticals Source Type: clinical trials
Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation
Conditions: Newly Diagnosed Multiple Myeloma Interventions: Drug: Cyclophosphamide; Drug: Lenalidomide Sponsors: Jinling Hospital, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
Impact of Glycemic Control After Reperfusion on Acute Kidney Injury in Living Donor Liver Transplantation
Conditions: Acute Kidney Injury; Hyperglycemia; Hypoglycemia; End Stage Liver Disease Interventions: Other: Observational study, records of blood glucose level after reperfusion Sponsors: Asan Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Rakt outcome analysis
Conditions: Kidney Transplantation; Robotic Surgery Sponsors: Seoul National University Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
